PRESS RELEASE published on 09/17/2026 at 07:00, 3 days 15 hours ago Inside Information / Other news releases
BRIEF published on 09/16/2026 at 22:05, 4 days ago Innate Pharma and Sobi formalize their partnership Strategic Partnership Innate Pharma Phase 3 TELLOMAK-3 Sobi T-cell Lymphomas
BRIEF published on 09/16/2026 at 22:05, 4 days ago Innate Pharma and Sobi Partnership Becomes Effective Innate Pharma Lacutamab Sobi Partnership TELLOMAK-3 Study T-cell Lymphoma
PRESS RELEASE published on 09/16/2026 at 22:00, 4 days ago Inside Information / Other news releases Innate Pharma and Sobi partnership becomes effective after meeting closing conditions, triggering USD 75 million payment and commencing TELLOMAK-3 Phase 3 study in Q1 2027 Partnership Innate Pharma Closing Conditions Sobi TELLOMAK-3
BRIEF published on 09/10/2026 at 07:05, 10 days 15 hours ago Innate Pharma to Provide Financial Insights in Upcoming Conference Call Conference Call Business Strategy Financial Update Innate Pharma 2026 Results
BRIEF published on 09/10/2026 at 07:05, 10 days 15 hours ago Innate Pharma announces a conference on its half-year results Financial Results Conference Call Immunotherapy Innate Pharma Biopharmaceutical Partnerships
PRESS RELEASE published on 09/10/2026 at 07:00, 10 days 15 hours ago Inside Information / Other news releases Innate Pharma to host conference call on September 17, 2026, providing first half 2026 financial results and business update. Event details available on www.innate-pharma.com Financial Results Conference Call Biotechnology Business Update Innate Pharma
BRIEF published on 08/14/2026 at 11:35, 1 month 6 days ago Innate Pharma Announces Upcoming Conference Call and Webcast Conference Call Biotechnology Webcast Immunotherapy Innate Pharma
PRESS RELEASE published on 08/14/2026 at 11:30, 1 month 6 days ago Inside Information / Other news releases Innate Pharma to host conference call and webcast with key executives discussing latest updates. Event details available on company website Conference Call Biotechnology Webcast Immunotherapy Innate Pharma
BRIEF published on 08/14/2026 at 10:32, 1 month 6 days ago Innate Pharma Announces €30 Million Share Offering Biotechnology Investment Share Offering Innate Pharma ADC Portfolio
Published on 09/19/2026 at 00:55, 1 day 21 hours ago Gossan Resources Announces Changes to Board and Management
Published on 09/18/2026 at 22:00, 2 days ago Silver Tiger Announces Results of Annual and Special Meeting
Published on 09/18/2026 at 20:35, 2 days 2 hours ago Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Published on 09/18/2026 at 14:30, 2 days 8 hours ago AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
Published on 09/20/2026 at 15:10, 7 hours 34 minutes ago MSITEK Participates in New York Fashion Week Retail Innovation Lab
Published on 09/20/2026 at 09:05, 13 hours 39 minutes ago Huawei Digital Power Showcases Multi-Scenario Solutions Featuring Grid Forming and AI at IDEE 2026
Published on 09/20/2026 at 06:30, 16 hours 14 minutes ago Huawei Grid-Interactive AIDC Solution: Shaping the New Paradigm of AI Infrastructure
Published on 09/20/2026 at 04:35, 18 hours 9 minutes ago How to Achieve Sustainable Power Without Changing Your Existing Backup System
Published on 09/19/2026 at 16:40, 1 day 6 hours ago 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival Opens
Published on 09/18/2026 at 18:34, 2 days 4 hours ago Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/17/2026 at 17:40, 3 days 5 hours ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
